Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Stempeucel allogeneic cell therapy receives limited approval in India

May 31, 2016

ETHZ, Roche and Universität Zürich disclose CB2 receptor ligands

May 24, 2016

Novartis establishes global clinical program for heart failure Fortihfy

May 20, 2016

Merck & Co. announces ROMK channel blockers

May 19, 2016

European Commission approves Uptravi for pulmonary arterial hypertension

May 18, 2016

F. Hoffmann-La Roche discloses cytochrome P450 11B2 inhibitors

May 18, 2016

Bayer Yakuhin launches Ventavis inhalation solution

May 17, 2016

Bayer terminates riociguat phase II study

May 13, 2016

GIBH and University of Texas System divulge DDR1 inhibitors

May 13, 2016

Merck & Co. announces ROMK channel blockers

May 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.